Skip to main navigation Skip to search Skip to main content

Setting Our Sights on Infectious Diseases

  • Manu De Rycker
  • , David Horn
  • , Bree Aldridge
  • , Richard K. Amewu
  • , Clifton E. Barry
  • , Frederick S. Buckner
  • , Sarah Cook
  • , Michael A.J. Ferguson
  • , Nathalie Gobeau
  • , Jennifer Herrmann
  • , Paul Herrling
  • , William Hope
  • , Jennifer Keiser
  • , Maria Jose Lafuente-Monasterio
  • , Paul D. Leeson
  • , Didier Leroy
  • , Ujjini H. Manjunatha
  • , James McCarthy
  • , Timothy J. Miles
  • , Valerie Mizrahi
  • Olena Moshynets, Jacquin Niles, John P. Overington, John Pottage, Srinivasa P.S. Rao, Kevin D. Read, Isabela Ribeiro, Lynn L. Silver, Jen Southern, Thomas Spangenberg, Shyam Sundar, Caitlin Taylor, Wes Van Voorhis, Nicholas J. White, Susan Wyllie, Paul G. Wyatt, Ian H. Gilbert
  • University of Dundee
  • Tufts University
  • US Department of Health and Human Services
  • University of Washington
  • University of Glasgow
  • Medicines for Malaria Venture
  • Saarland University
  • Helmholtz Centre for Infection Research
  • Independent Consultant
  • University of Liverpool
  • Swiss Tropical and Public Health Institute Swiss TPH
  • University of Basel
  • GlaxoSmithKline
  • Paul Leeson Consulting Ltd.
  • Novartis USA
  • QIMR Berghofer Medical Research Institute
  • University of Cape Town
  • Institute of Molecular Biology and Genetics of National Academy of Sciences of Ukraine
  • Massachusetts Institute of Technology
  • Medicines Discovery Catapult
  • ViiV Healthcare
  • Drugs for Neglected Diseases Initiative
  • LL Silver Consulting
  • Lancaster University
  • Ares Trading SA
  • Banaras Hindu University, Institute of Medical Sciences
  • Mahidol-Oxford Tropical Medicine Research Unit

Research output: Contribution to journalReview articlepeer-review

19 Citations (Scopus)

Abstract

In May 2019, the Wellcome Centre for Anti-Infectives Research (WCAIR) at the University of Dundee, UK, held an international conference with the aim of discussing some key questions around discovering new medicines for infectious diseases and a particular focus on diseases affecting Low and Middle Income Countries. There is an urgent need for new drugs to treat most infectious diseases. We were keen to see if there were lessons that we could learn across different disease areas and between the preclinical and clinical phases with the aim of exploring how we can improve and speed up the drug discovery, translational, and clinical development processes. We started with an introductory session on the current situation and then worked backward from clinical development to combination therapy, pharmacokinetic/pharmacodynamic (PK/PD) studies, drug discovery pathways, and new starting points and targets. This Viewpoint aims to capture some of the learnings.

Original languageEnglish
Pages (from-to)3-13
Number of pages11
JournalACS Infectious Diseases
Volume6
Issue number1
DOIs
Publication statusPublished - 10 Jan 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Setting Our Sights on Infectious Diseases'. Together they form a unique fingerprint.

Cite this